| NCT04088396 |
A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With sJIA |
https://ClinicalTrials.gov/show/NCT04088396 |
Recruiting |
Eli Lilly and Company |
2023-04-07 |
| NCT03773978 |
A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT03773978 |
Recruiting |
Eli Lilly and Company |
2021-08-21 |
| NCT03773965 |
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT03773965 |
Recruiting |
Eli Lilly and Company |
2027-12-06 |
| NCT03311854 |
A Study to Investigate the Safety and Efficacy of an Anti-IFN-gamma mAb in Children With Systemic Juvenile Idiopathic Arthritis (sJIA) Developing Macrophage Activation Syndrome/ Secondary Hemophagocytic Lymphohistiocytosis (MAS/sHLH) |
https://ClinicalTrials.gov/show/NCT03311854 |
Active, not recruiting |
NovImmune SA |
2021-05-31 |
| NCT03301883 |
A Study of Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA) |
https://ClinicalTrials.gov/show/NCT03301883 |
Recruiting |
Hoffmann-La Roche |
2020-09-23 |
| NCT03286933 |
Yoga Therapy for Adolescents With Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT03286933 |
Completed |
Children’s Hospital Los Angeles |
2017-06-26 |
| NCT03116763 |
The iPeer2Peer Program for Adolescents With Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT03116763 |
Recruiting |
The Hospital for Sick Children |
2021-05-31 |
| NCT03092427 |
Probiotic Treatment in Juvenile Idiopathic Arthritis (JIA) |
https://ClinicalTrials.gov/show/NCT03092427 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-05-31 |
| NCT03069638 |
Intranasal Dexmedetomidine Sedation During Intra-articular Joint Injections in Pediatric Population |
https://ClinicalTrials.gov/show/NCT03069638 |
Recruiting |
University of Oulu |
2021-06-30 |
| NCT03031782 |
Secukinumab Safety and Efficacy in JPsA and ERA |
https://ClinicalTrials.gov/show/NCT03031782 |
Active, not recruiting |
Novartis |
2020-06-16 |
| NCT03008681 |
OHRQoL Evaluation After Functional Therapy in JIA Patients |
https://ClinicalTrials.gov/show/NCT03008681 |
Completed |
University of Messina |
2016-09-30 |
| NCT02991469 |
A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS) |
https://ClinicalTrials.gov/show/NCT02991469 |
Recruiting |
Sanofi |
2025-05-31 |
| NCT02977416 |
Oxidation Rates of the Different Substrates During Exercise in Children and Adolescents With Juvenile Idiopathic Arthritis. Case-control Study and Cases Treated / Cases Not Treated With Anti-TNFα |
https://ClinicalTrials.gov/show/NCT02977416 |
Recruiting |
University Hospital, Clermont-Ferrand |
2020-05-31 |
| NCT02954718 |
Video-Based Task Oriented Activity Training in Patients With Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT02954718 |
Completed |
Istanbul University |
2016-11-30 |
| NCT02840175 |
Treatment Tapering in JIA With Inactive Disease |
https://ClinicalTrials.gov/show/NCT02840175 |
Active, not recruiting |
Assistance Publique - Hôpitaux de Paris |
2019-10-29 |
| NCT02776735 |
An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA) |
https://ClinicalTrials.gov/show/NCT02776735 |
Recruiting |
Sanofi |
2021-10-31 |
| NCT02764346 |
iCanCope With Pain: Usability and Feasibility Testing of a Smartphone Application to Manage Pain in Youth With Arthritis |
https://ClinicalTrials.gov/show/NCT02764346 |
Completed |
The Hospital for Sick Children |
2019-12-31 |
| NCT02610166 |
Jointly Managing JIA Online: An Internet-based Psycho-educational Game for Children With JIA and Their Parents |
https://ClinicalTrials.gov/show/NCT02610166 |
Completed |
The Hospital for Sick Children |
2019-03-31 |
| NCT02592434 |
Efficacy Study Of Tofacitinib In Pediatric JIA Population |
https://ClinicalTrials.gov/show/NCT02592434 |
Completed |
Pfizer |
2019-05-16 |
| NCT01500551 |
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT01500551 |
Recruiting |
Pfizer |
2024-11-15 |
| NCT02522507 |
A Peer E-mentoring Intervention to Improve Employment |
https://ClinicalTrials.gov/show/NCT02522507 |
Recruiting |
Holland Bloorview Kids Rehabilitation Hospital |
2019-04-30 |
| NCT02505828 |
ARTEMIS Synovial Markers in Arthritis Childhood |
https://ClinicalTrials.gov/show/NCT02505828 |
Completed |
University Hospital, Montpellier |
2018-04-30 |
| NCT02479373 |
Exercise and Body Composition in Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT02479373 |
Completed |
Johns Hopkins University |
2015-10-31 |
| NCT02453880 |
Web-based CBT for Symptoms of Mild-to-Moderate Anxiety and Depression in Youth With Chronic Illness |
https://ClinicalTrials.gov/show/NCT02453880 |
Completed |
Stanford University |
2015-05-31 |
| NCT02398435 |
Therapeutic Use of Tadekinig Alfa in Adult-onset Still’s Disease |
https://ClinicalTrials.gov/show/NCT02398435 |
Completed |
AB2 Bio Ltd. |
2016-06-30 |
| NCT02396212 |
Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA |
https://ClinicalTrials.gov/show/NCT02396212 |
Completed |
Novartis |
2017-03-07 |
| NCT02334748 |
A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies |
https://ClinicalTrials.gov/show/NCT02334748 |
Completed |
Novartis |
2018-08-31 |
| NCT02296424 |
ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab |
https://ClinicalTrials.gov/show/NCT02296424 |
Completed |
Novartis |
2016-10-14 |
| NCT02277444 |
A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy |
https://ClinicalTrials.gov/show/NCT02277444 |
Active, not recruiting |
Janssen Research & Development, LLC |
2018-07-09 |
| NCT02263703 |
Immunogenicity of HPV Vaccine in Immunosuppressed Children |
https://ClinicalTrials.gov/show/NCT02263703 |
Completed |
The University of New South Wales |
2016-02-29 |
| NCT02196480 |
23-valent Polysaccharide Pneumococcal Vaccine in Juvenile Idiopathic Arthritis Patients Under Anti-TNF Therapy |
https://ClinicalTrials.gov/show/NCT02196480 |
Completed |
University of Sao Paulo |
2011-06-30 |
| NCT02191722 |
“Medikidz Explain JIA Comic Book- Hebrew” |
https://ClinicalTrials.gov/show/NCT02191722 |
Completed |
Rabin Medical Center |
2016-05-31 |
| NCT02165345 |
Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT02165345 |
Active, not recruiting |
Hoffmann-La Roche |
2020-09-15 |
| NCT02067962 |
Identification of Genes Involved in Juvenile Idiopathic Arthritis by Wholel Exome Sequencing |
https://ClinicalTrials.gov/show/NCT02067962 |
Completed |
University Hospital, Montpellier |
2014-09-24 |
| NCT02052167 |
Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT02052167 |
Completed |
medac GmbH |
2014-08-31 |
| NCT02030613 |
Effective Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT02030613 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2017-02-28 |
| NCT02001844 |
Foot Orthoses (FOs) on Pain, Quality of Life and the Gait With Children Diagnosed With JIA |
https://ClinicalTrials.gov/show/NCT02001844 |
Completed |
University of Newcastle, Australia |
2012-11-30 |
| NCT01986400 |
Virtual Peer-to-Peer (VP2P) Support Mentoring for Juvenile Idiopathic Arthritis (JIA): A Pilot RCT |
https://ClinicalTrials.gov/show/NCT01986400 |
Completed |
The Hospital for Sick Children |
2015-05-31 |
| NCT01904292 |
A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT01904292 |
Completed |
Hoffmann-La Roche |
2017-06-13 |
| NCT01904279 |
A Study of Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA) |
https://ClinicalTrials.gov/show/NCT01904279 |
Completed |
Hoffmann-La Roche |
2016-05-31 |
| NCT01844518 |
Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) |
https://ClinicalTrials.gov/show/NCT01844518 |
Active, not recruiting |
Bristol-Myers Squibb |
2015-03-12 |
| NCT01835470 |
Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan |
https://ClinicalTrials.gov/show/NCT01835470 |
Completed |
Bristol-Myers Squibb |
2015-11-24 |
| NCT01803321 |
Study to Evaluate the Safety and Tolerability of Two Doses of Rilonacept in Pediatric Subjects With Active Systemic Juvenile Idiopathic Arthritis (SJIA) |
https://ClinicalTrials.gov/show/NCT01803321 |
Completed |
Regeneron Pharmaceuticals |
2008-06-30 |
| NCT01734382 |
A Study of Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab) |
https://ClinicalTrials.gov/show/NCT01734382 |
Completed |
Hoffmann-La Roche |
2019-10-09 |
| NCT01727986 |
An Extension Long-Term Study of RoActemra/Actemra (Tocilizumab) in Patients With Polyarticular Juvenile Idiopathic Arthritis Who Completed The WA19977 Study |
https://ClinicalTrials.gov/show/NCT01727986 |
Completed |
Hoffmann-La Roche |
2015-11-30 |
| NCT01673919 |
A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis From France Who Completed WA19977 Core Study |
https://ClinicalTrials.gov/show/NCT01673919 |
Completed |
Hoffmann-La Roche |
2014-01-31 |
| NCT01667471 |
A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis Who Completed WA19977 Core Study |
https://ClinicalTrials.gov/show/NCT01667471 |
Completed |
Hoffmann-La Roche |
2013-08-31 |
| NCT01572896 |
An Internet-based Self-management Program for Adolescents With Arthritis |
https://ClinicalTrials.gov/show/NCT01572896 |
Completed |
The Hospital for Sick Children |
2016-03-31 |
| NCT01563185 |
Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT01563185 |
Completed |
Horizon Pharma Ireland, Ltd., Dublin Ireland |
2015-03-31 |
| NCT01550003 |
Pediatric Arthritis Study of Certolizumab Pegol |
https://ClinicalTrials.gov/show/NCT01550003 |
Active, not recruiting |
UCB Pharma |
2023-06-30 |
| NCT01544114 |
A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA) |
https://ClinicalTrials.gov/show/NCT01544114 |
Completed |
Horizon Pharma Ireland, Ltd., Dublin Ireland |
2015-02-28 |
| NCT01541917 |
Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT01541917 |
Completed |
Children’s Mercy Hospital Kansas City |
2016-04-30 |
| NCT01513902 |
Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA) |
https://ClinicalTrials.gov/show/NCT01513902 |
Completed |
Pfizer |
2015-12-31 |
| NCT01455701 |
A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA) |
https://ClinicalTrials.gov/show/NCT01455701 |
Completed |
Hoffmann-La Roche |
2016-07-28 |
| NCT01385826 |
Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT01385826 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2014-11-04 |
| NCT01358383 |
Assessment of Pharmacokinetics of a Single Oral Dose of VIMOVO in Healthy Adult Volunteers |
https://ClinicalTrials.gov/show/NCT01358383 |
Completed |
AstraZeneca |
2011-06-30 |
| NCT04337437 |
Clinical Study of Genakumab for Injection in Chinese Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT04337437 |
Recruiting |
GeneScience Pharmaceuticals Co., Ltd. |
2020-09-30 |
| NCT04205500 |
Treatment With Specific Carbohydrate Diet in Children With Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT04205500 |
Recruiting |
Uppsala University |
2021-09-01 |
| NCT04169828 |
The Ondansetron Premedication Trial in Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT04169828 |
Recruiting |
University of British Columbia |
2022-01-01 |
| NCT04168034 |
iParent2Parent Program for Parents of Children With Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT04168034 |
Recruiting |
The Hospital for Sick Children |
2021-09-01 |
| NCT04167488 |
Assessment of Physical Activity Among Juvenile Idiopathic Arthritis Children Performed With Actigraphy |
https://ClinicalTrials.gov/show/NCT04167488 |
Recruiting |
Centre Hospitalier Universitaire de Besancon |
2019-12-31 |
| NCT04133662 |
Sleep & Pain in Juvenile Arthritis |
https://ClinicalTrials.gov/show/NCT04133662 |
Recruiting |
The Hospital for Sick Children |
2021-03-31 |
| NCT04066205 |
Sleep Self-Management Intervention for Children With Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT04066205 |
Recruiting |
University of Washington |
2020-12-30 |
| NCT04018599 |
Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS |
https://ClinicalTrials.gov/show/NCT04018599 |
Completed |
Fresenius Kabi SwissBioSim GmbH |
2020-03-17 |
| NCT03913962 |
Health and Exercise Response in Children With Chronic and Auto-immune Pathologies |
https://ClinicalTrials.gov/show/NCT03913962 |
Recruiting |
University Hospital, Clermont-Ferrand |
2028-12-31 |
| NCT03858504 |
Yoga Versus Home Exercise Program in Children With Enthesitis Related Arthritis |
https://ClinicalTrials.gov/show/NCT03858504 |
Completed |
Pamukkale University |
2019-07-31 |
| NCT03780959 |
Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA) |
https://ClinicalTrials.gov/show/NCT03780959 |
Completed |
Amgen |
1998-07-08 |
| NCT03769168 |
An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA) |
https://ClinicalTrials.gov/show/NCT03769168 |
Recruiting |
Novartis |
2024-10-02 |
| NCT03731520 |
Determination of Exercise Behavior in Patients With Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT03731520 |
Active, not recruiting |
Istanbul University |
2018-12-30 |
| NCT03728478 |
STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS |
https://ClinicalTrials.gov/show/NCT03728478 |
Recruiting |
Istituto Giannina Gaslini |
2021-03-31 |
| NCT03725007 |
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT03725007 |
Recruiting |
AbbVie |
2021-07-31 |
| NCT03430388 |
Yellow Fever Vaccine in Patients With Rheumatic Diseases |
https://ClinicalTrials.gov/show/NCT03430388 |
Completed |
University of Sao Paulo General Hospital |
2018-03-24 |
| NCT01166750 |
Jointstrong Intervention for Juvenile Arthritis |
https://ClinicalTrials.gov/show/NCT01166750 |
Completed |
University of Kansas Medical Center |
2011-03-31 |
| NCT01166282 |
A Study of the Efficacy and Safety of Adalimumab in Pediatric Subjects With Enthesitis Related Arthritis |
https://ClinicalTrials.gov/show/NCT01166282 |
Completed |
AbbVie |
2012-11-30 |
| NCT01033656 |
Treatment of Refractory Adult-onset Still’s Disease With Anakinra: a Randomized Study |
https://ClinicalTrials.gov/show/NCT01033656 |
Completed |
University of Helsinki |
2010-03-31 |
| NCT01011179 |
Internet Self-Management Program With Telephone Support for Adolescents With Arthritis |
https://ClinicalTrials.gov/show/NCT01011179 |
Completed |
The Hospital for Sick Children |
2009-06-30 |
| NCT00988221 |
A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT00988221 |
Completed |
Hoffmann-La Roche |
2011-11-30 |
| NCT00962741 |
Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis |
https://ClinicalTrials.gov/show/NCT00962741 |
Completed |
Pfizer |
2011-06-30 |
| NCT00891046 |
An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever. |
https://ClinicalTrials.gov/show/NCT00891046 |
Completed |
Novartis |
2014-12-31 |
| NCT00889863 |
Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA) |
https://ClinicalTrials.gov/show/NCT00889863 |
Completed |
Novartis |
2011-09-30 |
| NCT03984669 |
(1,3)-Béta-D-Glucan Levels at Diagnosis of Juvenile Idiopathic Arthritis and Its Correlation With Activity’s Disease : a Cohort Sudy |
https://ClinicalTrials.gov/show/NCT03984669 |
Recruiting |
Centre Hospitalier Universitaire, Amiens |
2020-06-30 |
| NCT00815282 |
Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease |
https://ClinicalTrials.gov/show/NCT00815282 |
Completed |
UMC Utrecht |
2015-01-31 |
| NCT00807846 |
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects |
https://ClinicalTrials.gov/show/NCT00807846 |
Completed |
Pfizer |
2012-12-31 |
| NCT03833271 |
The Efficacy of Influenza Vaccine Program in Children With Juvenile Idiopathic Arthritis. A Single Centre Results From Hungary |
https://ClinicalTrials.gov/show/NCT03833271 |
Completed |
University of Pecs |
2019-09-30 |
| NCT01015547 |
Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT01015547 |
Completed |
Helsinki University Central Hospital |
2007-11-30 |
| NCT00792233 |
Determining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA |
https://ClinicalTrials.gov/show/NCT00792233 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2013-10-31 |
| NCT00775437 |
Active Juvenile Idiopathic Arthritis (JIA) Compassionate Use |
https://ClinicalTrials.gov/show/NCT00775437 |
Completed |
AbbVie |
2013-03-31 |
| NCT00731965 |
Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT00731965 |
Completed |
UMC Utrecht |
2012-05-31 |
| NCT00690573 |
Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00690573 |
Completed |
Abbott |
2010-03-31 |
| NCT00652925 |
A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA |
https://ClinicalTrials.gov/show/NCT00652925 |
Completed |
Pfizer |
2004-04-30 |
| NCT00642460 |
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA) |
https://ClinicalTrials.gov/show/NCT00642460 |
Completed |
Hoffmann-La Roche |
2009-09-30 |
| NCT00570934 |
Supplementation With Vitamin D, Calcium or Both on Calcium Absorption and Bone Mineral Content in Children With JRA |
https://ClinicalTrials.gov/show/NCT00570934 |
Completed |
University of Missouri-Columbia |
2002-02-28 |
| NCT00570661 |
Phase II, Open Label, International, Multicentre Clinical Trial to Investigate Safety and Efficacy of Oral ITF2357 in Patients With Active Systemic Onset Juvenile Idiopathic Arthritis (SOJIA) |
https://ClinicalTrials.gov/show/NCT00570661 |
Completed |
Italfarmaco |
2008-08-31 |
| NCT00534495 |
Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults |
https://ClinicalTrials.gov/show/NCT00534495 |
Completed |
Montefiore Medical Center |
2013-06-30 |
| NCT00487565 |
Clinical Investigation of the LCS® Complete Posterior Stabilized Mobile-bearing Total Knee System |
https://ClinicalTrials.gov/show/NCT00487565 |
Completed |
DePuy Orthopaedics |
2011-02-28 |
| NCT00465504 |
Comparison of Two Different Methods of Delivering Local Analgesia During Intra-articular Corticosteroid Injections in Children With Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT00465504 |
Completed |
University of British Columbia |
2007-12-31 |
| NCT00443430 |
Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT00443430 |
Completed |
Seattle Children’s Hospital |
2010-10-31 |
| NCT00426218 |
Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) |
https://ClinicalTrials.gov/show/NCT00426218 |
Completed |
Novartis |
2010-03-31 |
| NCT00420251 |
Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis |
https://ClinicalTrials.gov/show/NCT00420251 |
Completed |
Ludwig-Maximilians - University of Munich |
NA |
| NCT00339157 |
Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS |
https://ClinicalTrials.gov/show/NCT00339157 |
Completed |
Institut National de la Santé Et de la Recherche Médicale, France |
NA |
| NCT00289107 |
Randomized Fixed Bearing vs Mobile Bearing Cruciate Substituting TKA |
https://ClinicalTrials.gov/show/NCT00289107 |
Completed |
DePuy Orthopaedics |
2009-09-30 |
| NCT00289094 |
Randomized Fixed Bearing vs Mobile Bearing Cruciate Retaining TKA |
https://ClinicalTrials.gov/show/NCT00289094 |
Completed |
DePuy Orthopaedics |
2009-09-30 |
| NCT00279747 |
A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA) |
https://ClinicalTrials.gov/show/NCT00279747 |
Completed |
Boehringer Ingelheim |
2003-01-31 |
| NCT00213187 |
PEAK Study (Physical Exercise and Activity in Kids) |
https://ClinicalTrials.gov/show/NCT00213187 |
Completed |
The Hospital for Sick Children |
NA |
| NCT00144664 |
Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) |
https://ClinicalTrials.gov/show/NCT00144664 |
Completed |
Chugai Pharmaceutical |
2005-04-30 |
| NCT00144625 |
Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) |
https://ClinicalTrials.gov/show/NCT00144625 |
Completed |
Chugai Pharmaceutical |
2005-07-31 |
| NCT00144612 |
Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA) |
https://ClinicalTrials.gov/show/NCT00144612 |
Completed |
Chugai Pharmaceutical |
2005-06-30 |
| NCT00144599 |
Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA) |
https://ClinicalTrials.gov/show/NCT00144599 |
Completed |
Chugai Pharmaceutical |
NA |
| NCT00130637 |
Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis |
https://ClinicalTrials.gov/show/NCT00130637 |
Completed |
National Institutes of Health Clinical Center (CC) |
2008-05-31 |
| NCT00095173 |
BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00095173 |
Completed |
Bristol-Myers Squibb |
2006-06-30 |
| NCT00001614 |
The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00001614 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00048542 |
Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA) |
https://ClinicalTrials.gov/show/NCT00048542 |
Completed |
Abbott |
2005-01-31 |
| NCT00037648 |
Juvenile Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00037648 |
Completed |
Swedish Orphan Biovitrum |
2003-11-30 |
| NCT00036374 |
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00036374 |
Completed |
Centocor, Inc. |
NA |
| NCT00034853 |
Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA) |
https://ClinicalTrials.gov/show/NCT00034853 |
Completed |
Boehringer Ingelheim |
2003-06-30 |
| NCT00010335 |
Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders |
https://ClinicalTrials.gov/show/NCT00010335 |
Completed |
Fred Hutchinson Cancer Research Center |
2010-07-31 |
| NCT00000429 |
Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00000429 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
NA |
| NCT00001862 |
TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00001862 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00004420 |
Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00004420 |
Completed |
FDA Office of Orphan Products Development |
NA |